BioSpace News Archive

Biogen Inc. announced the company will present a variety of new data from its Alzheimer’s disease product portfolio and clinical development pipeline at the upcoming annual Clinical Trials on Alzheimer’s Disease conference (CTAD), held November 9-12 virtually and in Boston, Massachusetts.

Theratechnologies Inc. today announced that Paul Levesque, President and Chief Executive Officer, will present at the Credit Suisse 30th Annual Healthcare Conference on November 11, 2021 at 9:40 a.m. ET.

Tessera Therapeutics Announces R&D Collaboration with Cystic Fibrosis Foundation as Part of a Portfolio of Complementary Technologies Advanced by Flagship’s Pioneering Medicines to Treat Cystic Fibrosis

Spray drying is a drying technique used in the pharmaceutical industry to produce dry or coarse powder from liquid or slurry.

Neurodiagnostics or neurodiagnostic tests monitor and record electrical activities of patient’s brain, spinal cord and peripheral nerves.

Lentiviral vectors find utilization as a medium to make a delivery of foreign genetic material into a separate cell.

POXEL SA, a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis and rare disorders, announced its participation at upcoming investor and scientific conferences in November 2021.

CytoDyn Inc., a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced updated results from its current cancer study using leronlimab to treat 28 patients with CCR5+ Metastatic Triple-Negative Breast Cancer, who had failed at least two lines of previous therapy.

ITM Isotope Technologies Munich SE announced the presentation of the design of its new phase III trial, COMPOSE, with the radiopharmaceutical candidate n.c.a.

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced a peer-reviewed paper published in the journal Cell using the GeoMx® Digital Spatial Profiler and GeoMx Human Whole Transcriptome Atlas to address one of the more perplexing symptoms of COVID-19: Anosmia or the loss of smell.